Neta Erez

Professor Neta Erez

Title: Associate Professor, Head of the Laboratory of Tumor Biology group, Chair of the Department of Pathology, Sackler Faculty of Medicine,Tel Aviv University.

Country: Israel

Organisation: Tel Aviv University

Discipline: Cancer Biology

Prof. Erez began her academic career at the Weizmann Institute of Science. She performed her PhD in the field of molecular cell biology with Prof. Varda Rotter. Supported by a fellowship from the Cancer Research Institute (CRI), Prof. Erez carried out her postdoctoral research in the laboratory of Prof. Doug Hanahan at UCSF, working in the field of tumor biology (2005-2010). During her postdoctoral fellowship she demonstrated a novel role for cancer-associated fibroblasts in mediating tumor- promoting inflammation. She joined the Department of Pathology at the Sackler Faculty of Medicine in October 2010, and is currently the Department Chair.

The research of Dr. Erez is focused on the tumor microenvironment, cancer-related inflammation and the role of Cancer-Associated Fibroblasts (CAFs) in facilitating tumor progression and metastasis. Additionally, Prof. Erez is studying the role of neuroinflammation in melanoma brain metastasis. Prof. Erez studies these crucial aspects of cancer using mouse models of carcinogenesis and metastasis. The main goal of our research is to identify and characterize key molecular pathways in the communication between tumor cells and their microenvironment, that can be targeted by novel therapeutics.


Dr. Ghajar

Dr Cyrus Ghajar 

Country: USA

Organisation: Fred Hutchinson Cancer Research Center

Discipline: Cancer Biology

Cyrus Ghajar directs the Laboratory for the Study of Metastatic Microenvironments (LSM2) (URL: http://research.fhcrc.org/ghajar/en.html) in Fred Hutchinson Cancer Research Center's Translational Research Program. Broadly, he is interested in how distant tissue microenvironments influence the behavior of disseminated tumor cells (DTCs). Specifically, his laboratory is working to understand how tissues like lung, liver, bone marrow, brain and lymph node regulate survival, growth and therapeutic resistance of DTCs, and how local and systemic changes awaken DTCs. His ultimate interests lie in targeting dormant DTCs to prevent metastasis. 


Owen J Sansom

Professor Owen Sansom

Title: Director of CRUK Beatson Institute

Country: UK

Organisation: CRUK Beatson Institute

Discipline: Cancer Biology

The focus of his research is to understand the function of driver oncogene and tumour suppressor mutations in epithelial cancers. He has a particular interest in colorectal cancer and WNT signalling, pancreatic cancer and hepatocellular carcinoma.

Owen has published over 250 papers and been instrumental in the use of in vivo models to determine the molecular hallmarks of epithelial cancers and for translating therapeutic concepts prior to clinical trials.


Dr Tobias Zech

Dr Tobias Zech

Country: UK

Organisation: Institute of Translational Medicine

Discipline: Cellular and Molecular Physiology

Tobias has been a group leader at the Institute of Translation Medicine, University of Liverpool since 2014. His group aims to understand the fundamental mechanisms that enable cells to move in a 3D  tissue environment during tumour cell invasion. In particular, the group  focuses on the role of the actin cytoskeleton in nuclear force transduction and polarised receptor  trafficking in invasive migration. 


Dr Jen Morton

Dr Jen Morton 


Country: UK

Organisation: CRUK Beatson Institute

Discipline: Cancer Biology

Jen Morton is head of the CRUK PRECISION-Panc Preclinical Laboratory at the CRUK Beatson Institute in Glasgow, Scotland. PRECISION-Panc is a £13m project supported by Cancer Research UK, which aims to transform how we treat pancreatic cancer. The network brings together basic and translational scientists and clinicians, ensuring that discoveries from the lab can rapidly reach the patients. 

Jen's group focuses mainly on investigating the importance of mutations found in human pancreatic tumours using mouse models, profiling different genetic subsets of pancreatic cancer to better understand the disease and identify specific targets for therapy, and performing preclinical trials of targeted therapies in clinically and genetically relevant pancreatic cancer mouse models. She first started research into pancreatic cancer in 2004 at the University of Massachusetts, particularly focusing on genetically engineered mouse models of the disease, and in 2007, she joined the CRUK Beatson Institute to continue research into pancreatic cancer. She also manages the CRUK Glasgow Cancer Centre preclinical trials unit which supports preclinical trials activity across the centre, and is co-lead on the Pancreatic Cancer UK Future Leaders Academy based at the Beatson Institute.


National Speakers

Prof Ricky Johnstone

Prof Ruth Ganns

Dr Antonella Papa

Prof Roger Daly

Prof Jennifer Stow

Dr Belinda Parker

Prof Jane Visvader

Dr Tatyana Chtanova

Dr Guillermo Gomez

Dr John Lock

Dr Kate Poole

Dr Christine Chaffer

Prof Angel Lopez

Prof Stuart Pitson

Prof Patrick Humbert

Dr Michelle McDonald

Prof Alpha Yap

Dr Ben Parker

Dr Matt Dun

A/Prof Michael Samuel

Prof Robin Anderson

A/Prof Edwin Hawkins

Prof Kum Kum Khanna

Dr Archa Fox

Dr Isabelle Lucet

Dr Emma Gordon

Site by MooballIT

Personal tools